Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Clin Microbiol ; 58(12)2020 11 18.
Artigo em Inglês | MEDLINE | ID: mdl-32907994

RESUMO

Nontyphoidal Salmonella (NTS) are among the most common etiological agents of diarrheal diseases worldwide and have become the most commonly detected bacterial pathogen in children hospitalized with diarrhea in Vietnam. Aiming to better understand the epidemiology, serovar distribution, antimicrobial resistance (AMR), and clinical manifestation of NTS gastroenteritis in Vietnam, we conducted a clinical genomics investigation of NTS isolated from diarrheal children admitted to one of three tertiary hospitals in Ho Chi Minh City. Between May 2014 and April 2016, 3,166 children hospitalized with dysentery were recruited into the study; 478 (∼15%) children were found to be infected with NTS by stool culture. Molecular serotyping of the 450 generated genomes identified a diverse collection of serogroups (B, C1, C2 to C3, D1, E1, G, I, K, N, O, and Q); however, Salmonella enterica serovar Typhimurium was the most predominant serovar, accounting for 41.8% (188/450) of NTS isolates. We observed a high prevalence of AMR to first-line treatments recommended by WHO, and more than half (53.8%; 242/450) of NTS isolates were multidrug resistant (MDR; resistant to ≥3 antimicrobial classes). AMR gene detection positively correlated with phenotypic AMR testing, and resistance to empirical antimicrobials was associated with a significantly longer hospitalization (0.91 days; P = 0.04). Our work shows that genome sequencing is a powerful epidemiological tool to characterize the serovar diversity and AMR profiles in NTS. We propose a revaluation of empirical antimicrobials for dysenteric diarrhea and endorse the use of whole-genome sequencing for sustained surveillance of NTS internationally.


Assuntos
Anti-Infecciosos , Gastroenterite , Antibacterianos/farmacologia , Anti-Infecciosos/farmacologia , Criança , Criança Hospitalizada , Farmacorresistência Bacteriana , Farmacorresistência Bacteriana Múltipla/genética , Gastroenterite/epidemiologia , Genômica , Humanos , Testes de Sensibilidade Microbiana , Sorotipagem , Vietnã/epidemiologia
2.
Clin Infect Dis ; 66(4): 504-511, 2018 02 01.
Artigo em Inglês | MEDLINE | ID: mdl-29029149

RESUMO

Background: Pediatric diarrheal disease presents a major public health burden in low- to middle-income countries. The clinical benefits of empirical antimicrobial treatment for diarrhea are unclear in settings that lack reliable diagnostics and have high antimicrobial resistance (AMR). Methods: We conducted a prospective multicenter cross-sectional study of pediatric patients hospitalized with diarrhea containing blood and/or mucus in Ho Chi Minh City, Vietnam. Clinical parameters, including disease outcome and treatment, were measured. Shigella, nontyphoidal Salmonella (NTS), and Campylobacter were isolated from fecal samples, and their antimicrobial susceptibility profiles were determined. Statistical analyses, comprising log-rank tests and accelerated failure time models, were performed to assess the effect of antimicrobials on disease outcome. Results: Among 3166 recruited participants (median age 10 months; interquartile range, 6.5-16.7 months), one-third (1096 of 3166) had bloody diarrhea, and 25% (793 of 3166) were culture positive for Shigella, NTS, or Campylobacter. More than 85% of patients (2697 of 3166) were treated with antimicrobials; fluoroquinolones were the most commonly administered antimicrobials. AMR was highly prevalent among the isolated bacteria, including resistance against fluoroquinolones and third-generation cephalosporins. Antimicrobial treatment and multidrug resistance status of the infecting pathogens were found to have no significant effect on outcome. Antimicrobial treatment was significantly associated with an increase in the duration of hospitalization with particular groups of diarrheal diseases. Conclusions: In a setting with high antimicrobial usage and high AMR, our results imply a lack of clinical benefit for treating diarrhea with antimicrobials; adequately powered randomized controlled trials are required to assess the role of antimicrobials for diarrhea.


Assuntos
Antibacterianos/uso terapêutico , Diarreia/tratamento farmacológico , Farmacorresistência Bacteriana Múltipla , Fezes/microbiologia , Adolescente , Campylobacter/efeitos dos fármacos , Criança , Pré-Escolar , Estudos Transversais , Diarreia/microbiologia , Feminino , Humanos , Lactente , Masculino , Testes de Sensibilidade Microbiana , Prevalência , Estudos Prospectivos , Salmonella/efeitos dos fármacos , Shigella/efeitos dos fármacos , Resultado do Tratamento , Vietnã
3.
Am J Trop Med Hyg ; 92(5): 1045-52, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25802437

RESUMO

We performed a prospective multicenter study to address the lack of data on the etiology, clinical and demographic features of hospitalized pediatric diarrhea in Ho Chi Minh City (HCMC), Vietnam. Over 2,000 (1,419 symptomatic and 609 non-diarrheal control) children were enrolled in three hospitals over a 1-year period in 2009-2010. Aiming to detect a panel of pathogens, we identified a known diarrheal pathogen in stool samples from 1,067/1,419 (75.2%) children with diarrhea and from 81/609 (13.3%) children without diarrhea. Rotavirus predominated in the symptomatic children (664/1,419; 46.8%), followed by norovirus (293/1,419; 20.6%). The bacterial pathogens Salmonella, Campylobacter, and Shigella were cumulatively isolated from 204/1,419 (14.4%) diarrheal children and exhibited extensive antimicrobial resistance, most notably to fluoroquinolones and third-generation cephalosporins. We suggest renewed efforts in generation and implementation of policies to control the sale and prescription of antimicrobials to curb bacterial resistance and advise consideration of a subsidized rotavirus vaccination policy to limit the morbidity due to diarrheal disease in Vietnam.


Assuntos
Infecções Bacterianas/epidemiologia , Infecções por Caliciviridae/epidemiologia , Diarreia/complicações , Norovirus/isolamento & purificação , Infecções por Rotavirus/epidemiologia , Anti-Infecciosos/farmacologia , Bactérias/efeitos dos fármacos , Infecções Bacterianas/complicações , Infecções Bacterianas/microbiologia , Infecções por Caliciviridae/complicações , Infecções por Caliciviridae/microbiologia , Pré-Escolar , Estudos Transversais , Demografia , Diarreia/epidemiologia , Diarreia/microbiologia , Feminino , Hospitalização , Humanos , Lactente , Masculino , Testes de Sensibilidade Microbiana , Norovirus/efeitos dos fármacos , Estudos Prospectivos , Rotavirus/efeitos dos fármacos , Rotavirus/isolamento & purificação , Infecções por Rotavirus/complicações , Infecções por Rotavirus/microbiologia , Estações do Ano , Vietnã/epidemiologia
4.
Proc Natl Acad Sci U S A ; 110(43): 17522-7, 2013 Oct 22.
Artigo em Inglês | MEDLINE | ID: mdl-24082120

RESUMO

Shigella sonnei is a human-adapted pathogen that is emerging globally as the dominant agent of bacterial dysentery. To investigate local establishment, we sequenced the genomes of 263 Vietnamese S. sonnei isolated over 15 y. Our data show that S. sonnei was introduced into Vietnam in the 1980s and has undergone localized clonal expansion, punctuated by genomic fixation events through periodic selective sweeps. We uncover geographical spread, spatially restricted frontier populations, and convergent evolution through local gene pool sampling. This work provides a unique, high-resolution insight into the microevolution of a pioneering human pathogen during its establishment in a new host population.


Assuntos
Disenteria Bacilar/epidemiologia , Doenças Endêmicas , Variação Genética , Shigella sonnei/genética , Antibacterianos/uso terapêutico , Criança , Pré-Escolar , Cromossomos Bacterianos/genética , Ciprofloxacina/uso terapêutico , Disenteria Bacilar/tratamento farmacológico , Disenteria Bacilar/microbiologia , Evolução Molecular , Fluoroquinolonas/uso terapêutico , Gatifloxacina , Genoma Bacteriano/genética , Genômica/métodos , Geografia , Humanos , Lactente , Dados de Sequência Molecular , Taxa de Mutação , Filogenia , Análise de Sequência de DNA , Shigella sonnei/classificação , Shigella sonnei/fisiologia , Vietnã/epidemiologia
6.
Infect Genet Evol ; 18: 335-43, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23612321

RESUMO

Norovirus (NoV) is a major cause of epidemic gastroenteritis in industrialized countries, yet the epidemiological significance of NoV in industrializing countries remains poorly understood. The spatiotemporal distribution of NoV genotypes identified in 2054 enrolled children was investigated between May 2009 and December 2010, in Ho Chi Minh City (HCMC), Vietnam. A total of 315 NoV extracted from stool samples were genotyped and GPS mapped to their source. Genogroup II NoV, particularly GII.4, were predominant, and the GII.4 strains could be subgrouped into GII.4-2006b (Minerva) and GII.4-2010 (New Orleans) variants. There was no spatiotemporal structure among the endemic GII strains; yet a significant spatiotemporal signal corresponding with the novel introduction of GII.4-2010 variant was detected. These data show that NoV GII.4 variants are highly endemic in HCMC and describe a scenario of rapid NoV strain replacement occurring in HCMC in early 2010.


Assuntos
Infecções por Caliciviridae/virologia , Gastroenterite/virologia , Norovirus/classificação , Pré-Escolar , Análise por Conglomerados , Fezes/virologia , Genótipo , Sistemas de Informação Geográfica , Humanos , Lactente , Recém-Nascido , Norovirus/genética , Norovirus/isolamento & purificação , Filogeografia , Análise Espaço-Temporal , Vietnã
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA